AUTL Autolus Therapeutics Ltd

USD 4.25 0.00 0
Icon

Autolus Therapeutics Ltd (AUTL) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 4.25

0.00 (0.00)%

USD 1.13B

5.06M

USD 9.38(+120.59%)

N/A

Icon

AUTL

Autolus Therapeutics Ltd (USD)
COMMON STOCK | NSD
USD 4.25
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 1.13B

N/A

USD 4.25

Autolus Therapeutics Ltd (AUTL) Stock Forecast

Show ratings and price targets of :
USD 9.38
(+120.59%)

Based on the Autolus Therapeutics Ltd stock forecast from 3 analysts, the average analyst target price for Autolus Therapeutics Ltd is USD 9.38 over the next 12 months. Autolus Therapeutics Ltd’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Autolus Therapeutics Ltd is Bearish, which is based on 1 positive signals and 6 negative signals. At the last closing, Autolus Therapeutics Ltd’s stock price was USD 4.25. Autolus Therapeutics Ltd’s stock price has changed by +23.19% over the past week, -6.18% over the past month and +68.65% over the last year.

No recent analyst target price found for Autolus Therapeutics Ltd
No recent average analyst rating found for Autolus Therapeutics Ltd

Company Overview Autolus Therapeutics Ltd

Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer and autoimmune diseases. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational t...Read More

https://www.autolus.com

The MediaWorks, London, United Kingdom, W12 7FP

463

September

USD

USA

Adjusted Closing Price for Autolus Therapeutics Ltd (AUTL)

Loading...

Unadjusted Closing Price for Autolus Therapeutics Ltd (AUTL)

Loading...

Share Trading Volume for Autolus Therapeutics Ltd Shares

Loading...

Compare Performance of Autolus Therapeutics Ltd Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for AUTL

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Autolus Therapeutics Ltd (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc 0.00 (0.00%) USD127.00B 31.94 20.00

ETFs Containing AUTL

Symbol Name AUTL's Weight Expense Ratio Price(Change) Market Cap
TQSM:CA
TD Q U.S. Small-Mid-Cap E.. 1.90 % 0.00 % 0.00 (0.00%) USD0.19B

Frequently Asked Questions About Autolus Therapeutics Ltd (AUTL) Stock

Based on ratings from 3 analysts Autolus Therapeutics Ltd's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 8 buy, sell and hold ratings.

Unfortunately we do not have enough data on AUTL's stock to indicate if its a good dividend stock.

Based on targets from 3 analysts, the average taret price for AUTL is USD 9.38 over the next 12 months. The maximum analyst target price is USD 11 while the minimum anlayst target price is USD 8.

Unfortunately we do not have enough data on AUTL's stock to indicate if its overvalued.

The last closing price of AUTL's stock was USD 4.25.

The most recent market capitalization for AUTL is USD 1.13B.

Based on targets from 3 analysts, the average taret price for AUTL is projected at USD 9.38 over the next 12 months. This means that AUTL's stock price may go up by +120.59% over the next 12 months.

Following are ETFs with the highest allocation to Autolus Therapeutics Ltd's stock :

TQSM:CA

As per our most recent records Autolus Therapeutics Ltd has 463 Employees.

Autolus Therapeutics Ltd's registered address is The MediaWorks, London, United Kingdom, W12 7FP. You can get more information about it from Autolus Therapeutics Ltd's website at https://www.autolus.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...